Skip to main content
. Author manuscript; available in PMC: 2010 Jul 16.
Published in final edited form as: Pharmacogenet Genomics. 2008 Dec;18(12):1059–1070. doi: 10.1097/FPC.0b013e3283131661

Table 2.

Summary of clinical and molecular data for 21 Chinese families carrying the A1555G mutation

Pedigree Number of matrilineal relatives Penetrance (including the use of drugs) (%)a Penetrance (excluding the use of drugs) (%) Average age-at-onset (excluding the use of drugs) Second mtDNA mutations mtDNA haplogroup
WZD31 12 66.7 50 14 tRNAThr G15927A B5b1
WZD32 12 66.7 41.7 13 tRNAThr G15927A B5b1
WZD33 27 51.9 44.4 16 tRNAThr G15927A B5b1
WZD34 19 50 39 15 tRNAThr G15927A B5b1
WZD1 [25] 17 5.9 0 None B4C1C1
WZD2 21 9.5 4.7 19 None D4a
WZD3 16 12.5 0 None D5a2
WZD4 24 29.2 16.7 20 None F1a1
WZD5 31 3.2 0 None D52b
WZD6 8 25 12.5 19 None D4b2b
WZD7 30 10 3.3 21 None D5a2
BJ101 [14] 14 5 0 None F3
BJ102 13 13 8 18 None N9a1
BJ103 20 5 0 None D4a
BJ104 11 4 0 None D4b2b
BJ105 [15] 15 67 45 tRNACys G5821A F3
BJ106 [24] 18 33 33 None M7b
BJ107 [22] 34 35 24 tRNAThr T15908C N
BJ108 16 63 38 tRNAGlu A14693G F
BJ109 9 67 44 tRNAArg T10454C M
BJ110 [14] 17 59 5.9 CO1/tRNASer(UCN) G7444A D4a

mtDNA, mitochondrial DNA.

a

Affected matrilineal relatives/total matrilineal relatives.